MedPath

Cost effectiveness of a collaborative stepped care intervention for anxiety disorders in the primary care setting.

Completed
Conditions
Generalised anxiety disorder
panic disorder
Registration Number
NL-OMON31723
Lead Sponsor
Zorgonderzoek Nederland (ZON)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
174
Inclusion Criteria

Patients who visit the GP practice and meet the DSM-IV diagnosis for GAD or PD are included in the study.

Exclusion Criteria

Suicidal, psychotic, cognitive deterioration.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>*outcome parameters: Baseline measurememts: The mini-International<br /><br>Neuropsychiatric Interview (MINI<br /><br>28;29) is administered for the classification of symptoms and the BAI for<br /><br>measurement of severity.<br /><br>Primary outcome measure is reduction of GAD or PD symptoms as measured by the<br /><br>BAI. Secondary<br /><br>outcome measures are remittance of GAD or PD as measured with MINI and the BAI<br /><br>(score below 10;<br /><br>range 0-61), adherence and compliance, and the Patient-Doctor Relationship<br /><br>Questionnaire (PDRQ-9).<br /><br>The number and intensity of functional somatic complaints a patient is<br /><br>experiencing is assessed with the<br /><br>LKV (Lichamelijke Klachten Vragenlijst),(33) the Somatosensory amplification<br /><br>Scale(34) and the Whitely<br /><br>Index.(35) Health care use is assessed by the Scale for Medical Utilisation of<br /><br>Health Services.</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath